NCT05142358Completed
A Prospective Study to Evaluate Continuous Positive Airway Pressure Devices to Reduce Pulmonary Dose
Source: ClinicalTrials.gov · Last updated 2 Feb 2026
Brief summary (registry, in English)
Data collection and assessment on patients with left-sided breast cancer or undergoing lung stereotactic body radiation therapy (SBRT) utilizing continuous positive airway pressure (CPAP) devices.
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 8 (actual)
- First submitted
- 4 Oct 2021
- Start date
- 19 Oct 2022
- Primary completion date
- 28 Jan 2026
- Lead sponsor
- Case Comprehensive Cancer Center
- Diseases
- Lung cancer
- NCT number
- NCT05142358
What you commit to
- Study type: Interventional
- Participants enrolled: 8
- From 19 Oct 2022 to the primary completion date, 28 Jan 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Patients with right side breast cancer
Other
- Patients who are unable to tolerate the CPAP device
Who the study is looking for
- Patients with left-sided breast cancers
- Patients must be undergoing left breast/chest wall radiation with or without regional nodal irradiation
- Patients undergoing lung SBRT
- Primary lung cancers
- Metastatic lung tumors
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center Coordinator of this site? Confirm its status | Cleveland | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.